Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody is an antibody specific for CEACAM5 protein. CEACAM5, also known as fetal antigen 5 (CEA), is a membranous cell adhesion molecule that is often expressed on the surface of a variety of cancer cells, especially in cancers of the digestive tract, pancreas, and breast.
Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market is projected to reach US$ 894.4 million in 2029, increasing from US$ 394.6 million in 2022, with the CAGR of 12.4% during the period of 2024 to 2029. Demand from Flow Cytometry and ELISA are the major drivers for the industry.
This antibody can bind to CEACAM5 protein to help detect and localize cancer cells, and can also be used in immunohistochemistry and cancer diagnosis. Due to the high expression of CEACAM5 in cancer, CEACAM5 antibodies have potential applications in tumor marker research and clinical diagnosis, helping to detect and monitor early cancer.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Sino Biological, Inc.
LifeSpan BioSciences, Inc
Abcam
Thermo Fisher Scientific (China) Co., Ltd.
Bio-Techne
Boster Biological Technology
Merck
RayBiotech, Inc.
Assay Genie
Creative Biolabs
MyBiosource, Inc.
OriGene Technologies, Inc.
Creative Diagnostics
Abbexa
Biorbyt
Abeomics Inc.
CUSABIO
Enzo Life Sciences, Inc.
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody introduction, etc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market is projected to reach US$ 894.4 million in 2029, increasing from US$ 394.6 million in 2022, with the CAGR of 12.4% during the period of 2024 to 2029. Demand from Flow Cytometry and ELISA are the major drivers for the industry.
This antibody can bind to CEACAM5 protein to help detect and localize cancer cells, and can also be used in immunohistochemistry and cancer diagnosis. Due to the high expression of CEACAM5 in cancer, CEACAM5 antibodies have potential applications in tumor marker research and clinical diagnosis, helping to detect and monitor early cancer.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Sino Biological, Inc.
LifeSpan BioSciences, Inc
Abcam
Thermo Fisher Scientific (China) Co., Ltd.
Bio-Techne
Boster Biological Technology
Merck
RayBiotech, Inc.
Assay Genie
Creative Biolabs
MyBiosource, Inc.
OriGene Technologies, Inc.
Creative Diagnostics
Abbexa
Biorbyt
Abeomics Inc.
CUSABIO
Enzo Life Sciences, Inc.
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Segment by Application
Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody introduction, etc. Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Antibody market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices